Health Care: Drugs

Biocryst Pharmaceuticals (BCRX: NASDAQ)

$1.79 0.09 | 5.29%
06/18/13 - 04:00 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 26.29M 19.64M 62.38M 74.59M
Cost of Sales 132.00K 0.00 86.46K 2.93M
Gross Operating Profit 26.16M 19.64M 62.29M 71.66M
Selling, General, and Administrative Expenses 6.83M 12.33M 14.18M 11.48M
Research & Development 51.46M 56.90M 82.47M 72.30M
Operating Income before D & A (EBITDA) -32.13M -49.59M -34.36M -12.12M
Depreciation & Amortization 1.07M 1.24M 2.27M 1.61M
Interest Income 222.00K 413.00K 503.54K 285.69K
Other Income - Net -749.00K -4.00M 0.00 0.00
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.48M -54.42M -36.12M -13.45M
Interest Expense 4.67M 3.77M 0.00 0.00
Pre-Tax Income -40.15M -58.19M -36.12M -13.45M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -39.08M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -39.08M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -39.08M -56.95M -33.85M -13.45M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -37.32M 0.00 0.00 0.00
Preferred Dividends
Net Income Available To Common -39.08M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -0.79 -1.26 -0.76 -0.35
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -0.79 -1.26 -0.76 -0.35
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.79 -1.26 -0.76 -0.35
Basic Normalized Net Income/Share -0.75 n.a. n.a. n.a.
EPS fr Continuing Ops. -0.79 -1.26 -0.76 -0.35
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -0.79 -1.26 -0.76 -0.35
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.79 -1.26 -0.76 -0.35
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.75 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with BCRX

View All

Latest BCRX Headlines from TheStreet

More Financial News for BCRX

Press Releases for BCRX

See All Press Releases

Partner Headlines for BCRX

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter